Terra Tech Corp (OTCMKTS:TRTC) continues to be an interesting player in the cannabis space. The most integrated name around, TRTC really does some of just about everything related to pot. And now, it would appear, Derek and the gang are getting into a new niche: The company just announced it has filed a patent application with the U.S. Patent and Trademark Office (USPTO) for innovative cannabis-infused rolling papers.
According to the release, “the inventive rolling papers, which are expected to launch in 2018, will be the latest addition to the Company’s portfolio of IVXX branded premium cannabis products, which includes flowers, concentrates, custom-rolled joints and edibles. As with all IVXX products, the rolling papers will be free of toxic pesticides, harmful molds and chemical residues.” The stock saw a muted immediate reaction to the news.
Terra Tech Corp (OTCMKTS:TRTC) has positioned itself in the cannabis space as a company that engages in the design, marketing, and sale of hydroponic equipment with proprietary technology to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine, California.
TRTC operates through two segments, Hydroponic Produce and Cannabis Products. The company offers environmental controllers and timers; ballasts; bulbs; reflectors; nutrients; and portable hydroponic trailers and The Big Bud and Little Bud, which are custom fabricated proprietary cultivation systems for horticulture enthusiasts, local urban farmers, and greenhouse growers
Additionally, TRTC operates as a retail seller of hydroponic produce, herbs, and floral products, which are distributed in the Midwest and the Northeast United States; and produces and sells a line of cannabis flowers and cigarettes, as well as a line of cannabis pure concentrates, including oils, waxes, shatters, and clears to dispensaries in California.
The company operates through multiple subsidiary businesses, including Blum, IVXX Inc., Edible Gardens, MediFarm LLC and GrowOp Technology.
Blum’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Blum offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations.
Find out when $TRTC reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
According to the release, the patent application covers the infusion of cannabis concentrates in rolling papers to achieve enhanced levels of active ingredients. Rolling papers with varying concentrations of cannabis concentrate, as well as with varying flavors and aromas, can be produced to achieve a personalized experience for the user. As part of Terra Tech’s aggressive IP protection program, the patent application is expected to ultimately mature into a fully enforceable issued patent to protect the Company’s proprietary technology.
Derek Peterson, CEO of Terra Tech, commented, “Infusing rolling papers with cannabis can enhance the user experience for adult-use and medical cannabis users alike, for example by customizing the amount of active ingredients available in a joint, without the need to manually add a concentrate to the flower in a joint. Furthermore, cannabis concentrate infused rolling papers can come in a range of different flavors. We are pleased to have filed this patent as we work toward growing our IP portfolio and expanding our range of premium quality cannabis products.”
Recent action has seen about -3% stripped out of share values of the listing over the past week of action. Market participants may want to pay attention to this stock. TRTC has a track record that includes a number of dramatic bounces. In addition, the listing has registered increased average transaction volume recently, with the past month seeing 14% beyond its prior sustained average level.
Currently trading at a market capitalization of $153.4M, TRTC has a significant war chest ($9.1M) of cash on the books, which must be weighed relative to about $576K in total current liabilities. TRTC is pulling in trailing 12-month revenues of $28.7M. However, the company is seeing declines on the top line on a quarterly y/y basis, with revenues falling at -19.1%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $TRTC stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: We hold no position in $TRTC, either long or short, and we have not been compensated for this article.